Journal Article Summary
The article investigates the relationship between smoking status and the effectiveness of clopidogrel compared to aspirin in patients who have experienced non-cardioembolic ischemic strokes. This topic is significant because smoking is a known risk factor for cardiovascular diseases, including strokes, and understanding how it influences treatment outcomes could improve patient care. Previous studies have suggested that smokers may experience better outcomes with clopidogrel, a medication that helps prevent blood clots, but this phenomenon, often referred to as the "smoker's paradox," had not been thoroughly explored in stroke patients.
The study included 1,792 patients who had suffered non-cardioembolic ischemic strokes and were treated with either clopidogrel or aspirin. The researchers categorized patients into current smokers and never-smokers, tracking their health outcomes over 12 months. They found that current smokers had a higher incidence of secondary strokes and other cardiovascular events compared to never-smokers. Interestingly, among smokers, those treated with clopidogrel showed a trend toward better outcomes compared to those on aspirin, although these results were not statistically significant.
However, the study has limitations that should be considered. It was a retrospective analysis, which may introduce biases, and the follow-up period was relatively short at just 12 months. Additionally, smoking status was only assessed at the time of hospital admission, which could change over time. Patients should discuss these findings with their healthcare providers, especially regarding smoking cessation and the choice of antiplatelet therapy, as these factors could significantly impact their long-term health outcomes.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Zhang Qian, Wang Yuan, Song Haiqing, Hou Chengbei, Cao Qingyu, Dong Kai, Huang Xiaoqin, Feng Wuwei, et al.. Clopidogrel and ischemic stroke outcomes by smoking status: Smoker’s paradox?. Journal of the neurological sciences 2016. DOI: 10.1016/j.jns.2016.12.025. PMID: 28131222. PMCID: PMC5800495.
Featured Pill Pals Product
OTC 1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
